In our case we had a parent company which was Maxigen who was interested in doing human therapeutics. That was their business. They saw the agriculture division as an entity that could bring in revenue, that could bring in partnerships to validate the technology and I don't think they were ... the...(Full transcript available to logged in subscribers.).
Register & Subscribe
Login
